[1]
“Crispr-Cas9 As A Tool For Correctng Oncogenic Mutations In Vitro Cancer Models”, JOC, vol. 24, no. 6s, pp. 753–761, Sep. 2025, doi: 10.64149/J.Carcinog.24.6s.753-761.